Skip to content

To compare the onset and duration of motor and sensory block and post op analgesia by adding two different drugs(clonidine or nalbuphine) to 0.5 %levobupivacaine in supraclavicular brachial plexus block in upper limb surgeries

A PLACEBO CONTROLLED STUDY TO COMPARE THE DURATION OF ANALGESIA OF CLONIDINE VS NALBUPHINE AS ADJUNCT TO LEVOBUPIVACAINE IN SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/06/025776
Enrollment
90
Registered
2020-06-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S599- Unspecified injury of elbow and forearm

Interventions

Intervention1: supraclavicular block in upper limb surgeries: to evaluate the duration of analgesia when clonodine or nalbuphine are used ad an adjuvant to levobupivacaine in supraclavicular brachial

Sponsors

department of anaesthesiology and critical care sgrdimsar vallah
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade I and II weight 40-80 kgs surgeries in upper limb

Exclusion criteria

Exclusion criteria: patients refusal local infection at needle insertion site coagulopathy patients on anti-coagulants allergy to local anaesthetics and study drug

Design outcomes

Primary

MeasureTime frame
to evaluate the duration of analgesia when clonidine or nalbuphine or placebo are used as an adjuvant to 0.5% levobupivacaine in supraclavicular blockTimepoint: onset of motor and sensory block will be done every minute after 10 minutes of injection of drug untill the block has been established sparing of dermatomes will be noted duration of sensory and motor block will be recorded duration of intraop analgesia is from onset of block to vas 40 will be noted post op analgesia will be assessed at regular intervals till 24 hours will be seen

Secondary

MeasureTime frame
procedure related and drug related complications will be seenTimepoint: intra op and post op till 24 hours after surgery

Countries

India

Contacts

Public ContactDr Shivika Aggarwal

Sri Guru Ram das institute of Medical Sciences And Research

kumarianitadr1@gmail.com9815632909

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026